IPSEN SA - AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED WITH 23.3% RECEIVING PLACEBO
IPSEN SA - AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED W
IPSEN SA - AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED W